World News: 11:30 GMT Monday 12th March 2018. [Sarepta Therapeutics, Inc. via Globe Newswire via SPi World News]
-- The Company met with the FDA Division of Neurology Products in February to obtain guidance on the regulatory pathway for golodirsen ---- The Company intends to complete a rolling NDA submission for golodirsen by year-end 2018 --CAMBRIDGE Mass March ...
Globe Newswire: 11:30 GMT Monday 12th March 2018
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.